What is the recommended vitamin D (cholecalciferol) repletion and maintenance regimen for a patient with vitamin D deficiency?

Vitamin D Deficiency Replacement Protocol

For severe vitamin D deficiency (25-OH-D ≤ 9 ng/mL), administer 50,000 IU of cholecalciferol weekly for 8–12 weeks, then continue with 800–2000 IU daily for maintenance, targeting serum levels of 30–50 ng/mL. 1

Loading Phase for Severe Deficiency

• Dosing regimen: Give 50,000 IU of vitamin D₃ (cholecalciferol) or vitamin D₂ (ergocalciferol) once weekly for 8–12 weeks to rapidly correct severe deficiency (25-OH-D ≤ 9 ng/mL). 1

• Preferred formulation: Vitamin D₃ is superior to D₂ for intermittent dosing because it maintains serum levels longer and has better pharmacokinetics. 1

• Alternative loading strategies: For patients requiring rapid correction, 6000 IU daily for 4–12 weeks is acceptable before transitioning to maintenance dosing. 2

• Dose calculation method: If you want precision, use this formula: Loading dose (IU) = 40 × (75 - current serum 25-OH-D) × body weight in kg. 3

Maintenance Phase

• Standard maintenance: After completing the loading phase, continue with 800–2000 IU daily to sustain adequate levels. 1

• Intermittent maintenance option: Alternatively, 100,000 IU every 3 months achieves similar efficacy to daily dosing for patients who prefer less frequent administration. 1

• Higher-risk populations: Obese patients, those with malabsorption syndromes, or patients on medications affecting vitamin D metabolism may require 7000 IU daily or 30,000–50,000 IU weekly for maintenance. 4

Target Serum Levels

• Optimal range: Aim for 25-OH-D concentrations of 30–50 ng/mL (75–125 nmol/L), which provides adequate protection for bone health and reduces disease risk. 1, 2

• Minimum threshold: Levels ≥ 30 ng/mL are sufficient for almost the entire population, while levels < 30 ng/mL constitute deficiency or inadequacy. 1, 5

Monitoring Strategy

• Timing of reassessment: Re-measure 25-OH-D at least 3 months after initiating therapy; for intermittent dosing, draw the level just before the next scheduled dose. 1

• Calcium monitoring: Check serum calcium (adjusted for albumin) 1 month after completing a loading regimen to unmask potential primary hyperparathyroidism. 5, 6

• Routine monitoring: Generally unnecessary once target levels are achieved, but consider repeat testing in patients with malabsorption, symptomatic deficiency, or suspected non-adherence. 1, 5

Dose-Response Principles

• Rule of thumb: Each 1000 IU daily raises serum 25-OH-D by approximately 10 ng/mL, though individual response varies. 1

• Weekly requirement estimate: Approximately 20,000–30,000 IU weekly (cumulative) is needed to reach target levels in severe deficiency. 1

• Dose adjustment: If levels remain < 30 ng/mL after the monitoring interval, increase the maintenance dose accordingly. 1

Safety Considerations

• Upper safety limit: Serum 25-OH-D > 100 ng/mL represents the upper safety threshold; daily doses up to 10,000 IU for several months are considered safe. 1

• Toxicity risk: Vitamin D toxicity causing hypercalcemia is rare and occurs only with daily intakes > 100,000 IU or serum levels > 100 ng/mL. 1

• Avoid annual bolus: Single 500,000 IU annual doses are associated with adverse outcomes and should be avoided. 1

• Contraindications: Do not use in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to vitamin D toxicity, or hypervitaminosis D. 7

Administration Recommendations

• Take with food: Vitamin D is fat-soluble and absorption is enhanced when taken with meals. 7

• Weekly vs. daily equivalence: Weekly dosing (50,000 IU) is not demonstrably inferior to daily dosing for repletion and reduces pill burden in patients with complex medication regimens. 8

• Product selection: Prescription ergocalciferol (Drisdol, Calciferol) 50,000 IU capsules are standard for loading regimens, while over-the-counter vitamin D₃ 1000–2000 IU tablets are appropriate for maintenance. 1

Common Pitfalls

• Inadequate dosing: The recommended daily allowance (600–800 IU) is grossly inadequate for correcting deficiency in most adults; approximately 5000 IU daily is typically needed for correction. 9

• Unmasking hyperparathyroidism: Vitamin D replacement can unmask significant hypercalcemia in patients with undiagnosed primary hyperparathyroidism, necessitating calcium monitoring. 6

• Obesity adjustment: Obese patients require higher doses due to sequestration of vitamin D in adipose tissue; consider body weight in dose calculations. 3, 4